Stay updated on Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.

Latest updates to the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a minor metadata update rather than a substantive change to the study content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new page revision label 'Revision: v3.5.3' has been added, signaling a version update to the page. This update does not modify the study content, eligibility criteria, or displayed data.SummaryDifference0.0%

- Check44 days agoChange DetectedRevision tag updated: v3.5.2 added; v3.5.0 removed.SummaryDifference0.0%

- Check58 days agoChange DetectedAdded Esophageal Carcinoma as a related topic and included a Resources entry for the Genetic and Rare Diseases Information Center on the page. This expands disease-topic coverage and provides an additional patient information resource.SummaryDifference0.1%

- Check65 days agoChange DetectedA new Revision: v3.5.0 is added. The Revision: v3.4.3 entry is removed.SummaryDifference0.0%

- Check80 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Decitabine+Tetrahydrouridine in Lung/Esophageal Ca Immunotherapy Clinical Trial page.